logoalt Hacker News

cthalupayesterday at 11:23 PM0 repliesview on HN

That's unfortunate! It might be worth checking out Tirzepatide or Retatrutide once it is released. The GIP and Glucagon receptors might be better targets for you, even if the GLP-1 receptor seems to not help.